Clinical Trial Update: CC-4047 and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Amyloidosis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating pomalidomide (CC-4047) plus dexamethasone in relapsed or refractory multiple myeloma and amyloidosis; results have been posted after co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyloidosis
• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Pomalidomide (Pomalidomide)

Snippet

Sponsor: Mayo Clinic | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2014-06-05